# Renin-Angiotensin System Studies

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/renin-angiotensin-system-studies/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers explores the role of the Renin-Angiotensin System in cardiovascular physiology and pathology, focusing on the mechanisms of action, physiological effects, and pathological implications of components such as Angiotensin, Renin, ACE2, and Angiotensin II Receptors. It covers topics including hypertension, cardiovascular disease, inflammation, fibrosis, and the potential therapeutic interventions such as Aliskiren in conditions like diabetes. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11001 |
| Works | 278 |

## Topic papers all

Showing 15 of 278.

- [A novel potent vasoconstrictor peptide produced by vascular endothelial cells](https://scholariq.org/papers/a-novel-potent-vasoconstrictor-peptide-produced-by-vascular-endothelial-cells/)
- [The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure](https://scholariq.org/papers/the-effect-of-spironolactone-on-morbidity-and-mortality-in-patients-with-severe/)
- [Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-versus-enalapril-in-heart-failure/)
- [Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol](https://scholariq.org/papers/cardiovascular-morbidity-and-mortality-in-the-losartan-intervention-for-endpoint/)
- [Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region](https://scholariq.org/papers/association-of-anxiety-related-traits-with-a-polymorphism-in-the-serotonin/)
- [A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure](https://scholariq.org/papers/a-randomized-trial-of-the-angiotensin-receptor-blocker-valsartan-in-chronic/)
- [Treatment of Hypertension in Patients 80 Years of Age or Older](https://scholariq.org/papers/treatment-of-hypertension-in-patients-80-years-of-age-or-older/)
- [Angiotensin-converting enzyme 2 protects from severe acute lung failure](https://scholariq.org/papers/angiotensin-converting-enzyme-2-protects-from-severe-acute-lung-failure/)
- [Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor](https://scholariq.org/papers/cloning-of-a-cdna-encoding-a-non-isopeptide-selective-subtype-of-the-endothelin/)
- [Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19](https://scholariq.org/papers/renin-angiotensin-aldosterone-system-inhibitors-in-patients-with-covid-19/)
- [Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk](https://scholariq.org/papers/genetic-variants-in-novel-pathways-influence-blood-pressure-and-cardiovascular/)
- [Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial](https://scholariq.org/papers/effect-of-angiotensin-converting-enzyme-inhibition-compared-with-conventional/)
- [Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II](https://scholariq.org/papers/effect-of-losartan-compared-with-captopril-on-mortality-in-patients-with/)
- [Non-Transgenic Mouse Models of Kidney Disease](https://scholariq.org/papers/non-transgenic-mouse-models-of-kidney-disease/)
- [Angiotensin-converting enzyme 2 is an essential regulator of heart function](https://scholariq.org/papers/angiotensin-converting-enzyme-2-is-an-essential-regulator-of-heart-function/)

## Topic primary papers

Showing 15 of 100.

- [Angiotensin-converting enzyme 2 protects from severe acute lung failure](https://scholariq.org/papers/angiotensin-converting-enzyme-2-protects-from-severe-acute-lung-failure/)
- [Angiotensin-converting enzyme 2 is an essential regulator of heart function](https://scholariq.org/papers/angiotensin-converting-enzyme-2-is-an-essential-regulator-of-heart-function/)
- [Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes](https://scholariq.org/papers/cardiorenal-end-points-in-a-trial-of-aliskiren-for-type-2-diabetes/)
- [The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease](https://scholariq.org/papers/the-intrarenal-renin-angiotensin-system-from-physiology-to-the-pathobiology-of/)
- [Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.](https://scholariq.org/papers/coronary-vasomotor-response-to-acetylcholine-relates-to-risk-factors-for/)
- [Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/aliskiren-combined-with-losartan-in-type-2-diabetes-and-nephropathy/)
- [Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors.](https://scholariq.org/papers/expression-cloning-of-type-2-angiotensin-ii-receptor-reveals-a-unique-class-of/)
- [Angiotensin-Converting Enzyme in the Human Heart](https://scholariq.org/papers/angiotensin-converting-enzyme-in-the-human-heart/)
- [Inflammation and angiotensin II](https://scholariq.org/papers/inflammation-and-angiotensin-ii/)
- [Classical Renin‐Angiotensin System in Kidney Physiology](https://scholariq.org/papers/classical-renin-angiotensin-system-in-kidney-physiology/)
- [Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients](https://scholariq.org/papers/aliskiren-a-novel-orally-effective-renin-inhibitor-provides-dose-dependent/)
- [Endothelial Nitric Oxide Synthase Gene Is Positively Associated With Essential Hypertension](https://scholariq.org/papers/endothelial-nitric-oxide-synthase-gene-is-positively-associated-with-essential/)
- [Renin-Angiotensin System Blockers and the COVID-19 Pandemic](https://scholariq.org/papers/renin-angiotensin-system-blockers-and-the-covid-19-pandemic/)
- [Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction](https://scholariq.org/papers/angiotensin-converting-enzyme-2-suppresses-pathological-hypertrophy-myocardial/)
- [Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin](https://scholariq.org/papers/inhibition-of-diabetic-nephropathy-by-a-decoy-peptide-corresponding-to-the/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.